Skip to main content

ScholarsBetaWeill Cornell Medicine

Browse About Sign in

Loading search results…

Scholars @ Weill Cornell Medicine

Help & supportPhase 1 prototype

Loading search results…

Browse

Scholars8,803 Publications201,993 Funding7,268 Clinical research1

FiltersClear all

Status

Completed1

Study type

Interventional1

Phase

Phase 2/31
Phase 211
Phase 37
Phase 44
Not applicable3
Not reported2
Phase 11

Investigator

Aliza B Solomon1

Department

Pediatrics1

Condition

Colitis, Ulcerative1
COVID-192
Coronavirus Infections2
Crohn Disease2
Leukemia, Myeloid, Acute2

Intervention type

Drug1

Sponsor type

Industry1

Start date

to

Has results posted1

Phase 2/3×Colitis, Ulcerative×Clear all

Showing 1–1 of 1 studySort:

CompletedInterventional · Phase 2/3NCT03398148 ↗
A Multicenter, Randomized, Double-Blind, Placebo Controlled Induction Study to Evaluate the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Ulcerative Colitis

Show all 50

Show fewer

Aliza B SolomonPI

Intervention: Drug: risankizumab IV · Drug: placebo for risankizumab · Drug: risankizumab SC
Dates: Mar 2018 – Nov 2022· Results posted
Sponsor: AbbVie Inc.

Ulcerative Colitis (UC)